This study will assess in women with a request for pain relief during labor the costeffectiveness of RPCA as first choice treatment compared to EA. Epidurale anesthesie meest effectieve vorm van pijnbestrijding. Echter de tevredenheid van de patient tav epidurale anesthesie vergeleken met remifentanil, in dit geval laag risico zwangere, is niet bekend.
Conditions
Interventions
Epidural anesthesia versus remifentanil.
First line pregnant women will be included. They will know which form of treatment they will get once they request pain control. If they don't use pain contro
Sponsors
AMC
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >18 years; 2. ASA physical status I or II; 3. Low risk pregnant women.
Exclusion criteria
Exclusion criteria: 1. Drug allergy: History of hypersensitivity to opioid or local anesthetic; 2. Substances; 3. Labor before 32 weeks or after 42 weeks of gestation; 4. Initial maternal SpO2 of less than 95%; 5. Initial maternal temperature of 38C or higher; 6. Prior administration of regional of opioid analgesia (during this delivery).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Costeffectiveness of RPCA as first choice treatment compared to EA in low risk pregnant women. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Pain appreciation; 2. Patient satisfaction; 3. Pain scores; 4. Maternal and neonatal side effects. | — |
Contacts
Public ContactSabine Logtenberg
Outcome results
None listed